ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
GeNeuro SA

GeNeuro SA (GNRO)

0,135
0,0105
(8,43%)
Geschlossen 22 Januar 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,135
Gebot
0,126
Fragen
0,147
Volumen
45.266
0,125 Tagesbereich 0,135
0,0428 52-Wochen-Bereich 2,35
Marktkapitalisierung
Handelsende
0,1245
Handelsbeginn
0,125
Letzte Trade
1
@
0.135
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
317.070
Ausgegebene Aktien
29.760.933
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-
Nettogewinn
-14,76M

Über GeNeuro SA

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Geneva, Che
Gegründet
-
GeNeuro SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNRO. The last closing price for GeNeuro was 0,12 €. Over the last year, GeNeuro shares have traded in a share price range of 0,0428 € to 2,35 €.

GeNeuro currently has 29.760.933 shares in issue. The market capitalisation of GeNeuro is 3,71 € million.

GNRO Neueste Nachrichten

De nouvelles données soutenant une nouvelle approche de médecine de précision pour les patients atteints de SLA avec le GNK-301 de GeNeuro présentées lors du 35e Symposium international sur la SLA/MMN

Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique dont l'objectif est de s'attaquer aux facteurs de progression des maladies neurodégénératives et...

GeNeuro SA Obtains the Opening of Debt-Restructuring Proceedings

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva...

GeNeuro: New Data Presented at the ECTRIMS 2025 Congress in Copenhagen Shows That Temelimab Rescues the Neurodegenerative Effects of HERV-W in an MS Model

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...

GeNeuro annonce déposer une requête de sursis concordataire au Tribunal de première instance de Genève

Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...

GeNeuro : Fin du contrat de liquidité conclu avec GILBERT DUPONT

Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0180.1250.14950.11451995970.13897054DE
40.065493.96551724140.06960.280.06744503840.13831129DE
120.061884.42622950820.07320.280.04283170700.12625319DE
260.045500.090.280.04281613170.12012825DE
52-1.115-89.21.252.350.04281058850.190097DE
156-3.565-96.35135135143.74.010.0428385800.34934466DE
260-3.155-95.8966565353.296.280.0428266150.74222211DE

GNRO - Frequently Asked Questions (FAQ)

What is the current GeNeuro share price?
The current share price of GeNeuro is 0,135 €
How many GeNeuro shares are in issue?
GeNeuro has 29.760.933 shares in issue
What is the market cap of GeNeuro?
The market capitalisation of GeNeuro is EUR 3,71M
What is the 1 year trading range for GeNeuro share price?
GeNeuro has traded in the range of 0,0428 € to 2,35 € during the past year
What is the reporting currency for GeNeuro?
GeNeuro reports financial results in EUR
What is the latest annual profit for GeNeuro?
The latest annual profit of GeNeuro is EUR -14,76M
What is the registered address of GeNeuro?
The registered address for GeNeuro is 18 CHEMIN DES AULX, PLAN-LES-OUATES, GENEVA, 1228
What is the GeNeuro website address?
The website address for GeNeuro is www.geneuro.com
Which industry sector does GeNeuro operate in?
GeNeuro operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DMSBSDiagnostic Medical Systems
0,007 €
(75,00%)
36,27k
POXELPoxel
0,3905 €
(60,04%)
6,13M
GTRDSGroupe Tera DS
0,12 €
(43,71%)
32,95k
MCPGrupo Media Capital Sgps Sa
2,00 €
(23,46%)
5
ALDOLDolfines
4,12 €
(21,00%)
82,74k
DRVDSDrone Volt DS
0,0009 €
(-50,00%)
707,14k
HYPDSHipay Group DS
0,011 €
(-45,00%)
32,76k
NICBSNicox SA
0,0178 €
(-22,61%)
11
ALGENGenoway S A Inh Eo 15
3,06 €
(-19,69%)
123,45k
ALBOOBOOSTHEAT
0,058 €
(-16,91%)
161k
ATOAtos SE
0,0022 €
(10,00%)
3,39B
BCPBanco Comercial Portugues SA
0,5124 €
(1,03%)
79,14M
ALCYBCybergun
0,0001 €
(0,00%)
31,06M
ALVERVergnet
0,0014 €
(-6,67%)
21,7M
EDPEDP SA
3,069 €
(-1,76%)
12,59M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock